Kedudukan dalam Saham
#39131
Exopharm Limited is an Australian clinical-stage firm dedicated to developing... Exopharm Limited is an Australian clinical-stage firm dedicated to developing groundbreaking therapeutics utilizing extracellular vesicles (EVs). Its core technologies include an extracellular vesicle positioning system (EVPS), which facilitates the precise targeting of exosomes by attaching specific molecules to their surface, guiding them to particular tissues or cell types. Another innovation is oligonucleotide packing, designed to optimize therapeutic delivery by preferentially loading specific RNA molecules into exosomes as medicinal cargo. Additionally, Exopharm employs ligand-based exosome affinity purification for effectively isolating and refining exosomes from biological fluids such as blood and cell culture media. The company's engineered EV product portfolio features Fortrexo CoV, aimed at treating SARS-CoV-2 infections; Cognevo, developed for neurodegenerative diseases; and PlexoDox, intended for cancer treatment. Exopharm Limited also maintains a research collaboration with Showa Denko Materials Co., Ltd. The company was founded in 2013 and is headquartered in Melbourne, Australia.
Harga Saham
$0.00700343
Disegerakkan terakhir: 2023-10-30
Perubahan (1 tahun)
0.00%
Perdagangan Exopharm Limited (EX1)
Harga EX1 dengan permodalan pasaran b
Modal pasaran bagi Exopharm Limited(EX1)
Modal Pasaran: $637.31K
Sehingga August 2026, Exopharm Limited mempunyai modal pasaran sebanyak $637.31K. Ini menjadikan Exopharm Limited syarikat ke-39131st paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Exopharm Limited dari 2018 hingga 2026
EX1 berbanding dengan 5 teratas yang paling popular stocks
| Harga EX1 |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.470T
|
+858,220,126.04%
|
|
|
|
|
$4.467T
|
+700,924,002.44%
|
|
|
|
|
$4.174T
|
+654,999,089.40%
|
|
|
|
|
$3.700T
|
+580,575,684.25%
|
|
|
|
|
$2.854T
|
+447,872,231.48%
|
